Organon & Co. (NYSE: OGN) has announced that it will be unveiling its third quarter financial results on Thursday 31st October 2024. The disclosure is planned to occur before market open.
Based on the predictions of financial experts on Wall Street, the enterprise is expected to reveal an anticipated $0.90 profit per share for the quarter. Additionally, the firm is poised to disclose a total revenue of $1.56 billion for the quarter.
During the same quarter of the previous year, the company's earnings report indicated a per-share income of $0.87. Moreover, the company generated a total revenue of $1.52 billion during that specific quarter.
Wall Street analysts have shared their forecasts for the company's annual performance, predicting a total revenue of $6.38 billion. Additionally, they expect the company to post profit of $4.28 per share for the fiscal year.
| Period | EPS Actual |
EPS Growth* |
Revenue Actual |
Revenue Growth* |
|---|---|---|---|---|
| Historical Earnings Insight | ||||
| Q2 2024 | $1.12 | -14.5% | 1.61 B | -0.1% |
| Q1 2024 | $1.22 | +9.9% | 1.62 B | +5.5% |
| Q4 2023 | $0.88 | +8.6% | 1.60 B | +7.6% |
| Q3 2023 | $0.87 | -34.1% | 1.52 B | -1.2% |
| Q2 2023 | $1.31 | +4.8% | 1.61 B | +1.5% |
| *Growth on year-over-year basis | ||||
In addition, The firm will review the third quarter financial results on 31st October 2024 at 08:30 AM eastern time, in a conference call with public.
Organon & Co. (OGN) shares traded as low as $17.20 and as high as $17.88 on a day volume of 3.11 million shares, closed Tuesday's regular trading session at $17.85, an upturn of 2.23 percent.
